Fresenius Se & Co. Kgaa · XETR:FRE
Fresenius Se & Co. Kgaa — Merger or Acquisition (September 2013)
9 slides from Fresenius Se & Co. Kgaa's merger presentation, Sep 13, 2013
Slide 1: Acquiring 43 Hospitals from Rhön-Klinikum AG
Acquiring 43 Hospitals from Rhön-Klinikum AG Conference Call, September 13, 2013
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive
Slide 3: Compelling Strategic Rationale
Compelling Strategic Rationale Unique opportunity - 43 hospitals, approx. 11,800 beds, 15 outpatient facilities to acquire highly - €2 bn sales and ~€250 m EBITDA in 2013 expected attractive clinic portfolio - Establish largest countrywide network with 117 hospitals and Perfect strategic ~€5.5 bn sa
Slide 4: Perfect Geographic Fit – HELIOS Hospital Network Pro Forma
Perfect Geographic Fit – HELIOS Hospital Network Pro Forma - Creating Europe’s largest hospital operator with ~€5.51 bn sales and >€750 m1 EBITDA - Majority of the German population have Nordenham Boizenburg access to a HELIOS hospital within one hour’s drive Uelzen Nienburg Wittingen Stolzenau Gifh
Slide 5: Substantial Synergies and Operating Efficiencies
Substantial Synergies and Operating Efficiencies Time Effect Short-term Approx. €85 m synergies p.a. before tax by 2015 (e.g. 50% increase in procurement volumes; economies of scale) - frontloads hospital development plan - detailed plan lowers execution risk One-time costs of approx. €80 m before t
Slide 6: Perfect Strategic Fit – Sources for Future Growth
Perfect Strategic Fit – Sources for Future Growth German-wide Hospital Presence as a Key Prerequisite Time Effect Selective approach due to broad regional presence; Privatization revenue target of ~€150 million p.a. (multi-year- Opportunities average) Yr 2 Increase admissions, e.g. combined acute/po
Slide 7: Financially Sound Acquisition
Financially Sound Acquisition Total - €3,070 m (debt-free) consideration - Approx. 12x EBITDA 2013e - 100% debt-financing Financing - No financing through capital increase or FMC shares Net - 2013: pro forma: 3.0-3.5x debt/EBITDA - 2014: upper end of 2.5-3.0x range - Acquisition expected to be EPS a
Slide 8: Share Information
Share Information Share key facts Number of shares1 178,763,259 WKN / ISIN 578560 / DE0005785604 Ticker symbol FRE Bloomberg symbol FRE GR Reuters symbol FREG.de ADR key facts Ratio 8 ADRs = 1 ordinary share ADR CUSIP / ISIN 35804M105 / US35804M1053 Ticker symbol FSNUY Exchange OTC-market Structure
Slide 9: Financial Calendar 2013
Financial Calendar 2013 05.11.2013 Report on 1st – 3rd quarter 2013 Contact Birgit Grund SVP Investor Relations Fresenius SE & Co. KGaA Telephone: +49 6172 608-2485 e-mail: Birgit.Grund@fresenius.com For further information and current news: http://www.fresenius.com Conference Call, Fresenius SE & C
Fresenius SE & Co. KGaA — Merger or Acquisition (September 2013) on 6ix